NeuroVision Imaging

company

About

NeuroVision Imaging is a developer of digital imaging and diagnostic solutions for Alzheimer's disease.

  • 1 - 10

Details

Last Funding Type
Series C
Last Funding Money Raised
$11.20M
Industries
Biotechnology,Health Care,Health Diagnostics,Machine Learning,Neuroscience
Founded date
Jan 1, 2010
Number Of Employee
1 - 10
Operating Status
Active

NeuroVision is an integrated neuroscience company focused on delivering scientifically validated, diagnostic tests & biomarkers for early detection and monitoring of amyloid pathology related to Alzheimer’s Disease. The company has developed a novel retinal imaging technology, which is currently being utilized in a number of clinical trials globally.With access to unique datasets, we provide data aggregation services, analysis, biostatistics, and applications of machine learning algorithms to large repositories of images and other biomarker data seeking to advance the collective understanding and prediction capabilities for neurodegenerative diseases.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$11.20M
NeuroVision Imaging has raised a total of $11.20M in funding over 2 rounds. Their latest funding was raised on May 2, 2018 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 2, 2018 Series C $11.20M 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
NeuroVision Imaging is funded by 2 investors. Whittier Ventures and Nikon-SBI Innovation Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Whittier Ventures Series C
Nikon-SBI Innovation Fund Series C